Home/Filings/4/0001213900-24-096887
4//SEC Filing

Holuka Eugene Myron 4

Accession 0001213900-24-096887

CIK 0001506251other

Filed

Nov 11, 7:00 PM ET

Accepted

Nov 12, 5:00 PM ET

Size

20.0 KB

Accession

0001213900-24-096887

Insider Transaction Report

Form 4
Period: 2024-11-07
Transactions
  • Award

    Stock Option (Right to Purchase Common Stock)

    2024-11-07+125,000125,000 total
    Exercise: $0.38Exp: 2034-11-07Common Stock (125,000 underlying)
Holdings
  • Stock Option (Right to Purchase Common Stock)

    Exercise: $1.01Exp: 2030-10-06Common Stock (35,000 underlying)
    35,000
  • Stock Option (Right to Purchase Common Stock)

    Exercise: $1.25Exp: 2032-10-04Common Stock (75,000 underlying)
    75,000
  • Stock Option (Right to Purchase Common Stock)

    Exercise: $0.67Exp: 2029-10-08Common Stock (25,000 underlying)
    25,000
  • Stock Option (Right to Purchase Common Stock)

    Exercise: $12.00Exp: 2026-06-23Common Stock (13,334 underlying)
    13,334
  • Common Stock

    2,367
  • Stock Option (Right to Purchase Common Stock)

    Exercise: $0.70Exp: 2033-10-10Common Stock (75,000 underlying)
    75,000
  • Stock Option (Right to Purchase Common Stock)

    Exercise: $2.04Exp: 2031-10-11Common Stock (75,000 underlying)
    75,000
  • Stock Option (Right to Purchase Common Stock)

    Exercise: $1.39Exp: 2030-07-07Common Stock (25,000 underlying)
    25,000
  • Stock Option (Right to Purchase Common Stock)

    Exercise: $3.45Exp: 2027-09-13Common Stock (10,000 underlying)
    10,000
  • Stock Option (Right to Purchase Common Stock)

    Exercise: $1.62Exp: 2028-09-04Common Stock (15,000 underlying)
    15,000
  • Stock Option (Right to Purchase Common Stock)

    Exercise: $2.00Exp: 2031-07-22Common Stock (15,000 underlying)
    15,000
  • Stock Option (Right to Purchase Common Stock)

    Exercise: $1.69Exp: 2031-02-16Common Stock (25,000 underlying)
    25,000
Footnotes (2)
  • [F1]The options were granted on November 7, 2024. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.
  • [F2]The options are vested in full and exercisable immediately.

Documents

1 file

Issuer

Citius Pharmaceuticals, Inc.

CIK 0001506251

Entity typeother

Related Parties

1
  • filerCIK 0001678292

Filing Metadata

Form type
4
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 5:00 PM ET
Size
20.0 KB